CVS Group (LON:CVSG - Get Free Report) had its price objective increased by stock analysts at Deutsche Bank Aktiengesellschaft from GBX 1,500 to GBX 1,700 in a research report issued on Tuesday, Marketbeat Ratings reports. The brokerage currently has a "buy" rating on the stock. Deutsche Bank Aktiengesellschaft's price target points to a potential upside of 20.20% from the company's current price.
CVSG has been the topic of several other reports. Royal Bank Of Canada increased their price objective on CVS Group from GBX 1,500 to GBX 1,900 and gave the company an "outperform" rating in a research report on Tuesday. Berenberg Bank reissued a "buy" rating and issued a GBX 2,000 target price on shares of CVS Group in a research report on Wednesday, October 15th. Finally, Peel Hunt reissued a "buy" rating and issued a GBX 1,600 target price on shares of CVS Group in a research report on Tuesday, October 7th. Four research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of GBX 1,800.
Get Our Latest Analysis on CVSG
CVS Group Trading Up 1.3%
LON CVSG opened at GBX 1,414.29 on Tuesday. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 110.52. CVS Group has a 12 month low of GBX 791 and a 12 month high of GBX 1,648. The stock has a market cap of £1.01 billion, a P/E ratio of 372.18, a P/E/G ratio of 1.77 and a beta of 1.02. The stock's fifty day moving average price is GBX 1,269.39 and its 200-day moving average price is GBX 1,218.42.
CVS Group (LON:CVSG - Get Free Report) last released its quarterly earnings data on Tuesday, October 7th. The company reported GBX 80.10 EPS for the quarter. CVS Group had a return on equity of 7.86% and a net margin of 3.20%. As a group, equities analysts forecast that CVS Group will post 93.9393939 EPS for the current fiscal year.
CVS Group Company Profile
(
Get Free Report)
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.